US Kidney Research Corp Achieves Major Technology Breakthrough

US Kidney Research Corporation (USKRC) is the first in the world to produce synthetic urine (urine produced synthetically from an artificial device) using a new blood purifying technology that involves filtration and ion transport processes similar to the native kidney. The ability to produce synthetic urine was demonstrated in animals (pigs) lacking kidney function using their latest prototype at Noble Life Sciences in Maryland

Roland Ludlow, Founder and CEO of USKRC said, “We are thrilled to be the first ever to accomplish this momentous breakthrough with our new artificial kidney prototype. It confirms that the electrodeionization technology we are using is right on track and that reaching our future goal of creating a wearable and ultimately an implantable artificial kidney is a real possibility. We are extremely proud of our science and medical advisor Dr. Ira Kurtz and the head of research at the University of Arkansas, Jamie Hestekin PhD, along with his staff, for their incredible work leading to this discovery.”

The testing results also revealed other significant advances including the ability to modulate the amount of potassium removed from the blood and transferred to the artificial urine under computer control. This is the only wearable artificial kidney technology where this capability is possible.

The company’s future plans include advancing their technology, miniaturizing their prototype, and testing biocompatibility of their technology for safety. They estimate that with adequate funding, human trials can be reached in approximately 2 years.

About US Kidney Research Corporation

US Kidney Research Corporation (USKRC) is a Delaware C-Corp founded in June, 2015. USKRC is a leader in the field of artificial kidney research and involved in R&D of the world’s first waterless renal replacement technology.

Contrary to dialysis, their new technology does not require purified water, dialysate concentrate solutions, or a dialyzer, providing significant advantages for both the patient and provider. Their novel waterless blood purification technology is leading to the creation of a truly artificial kidney to replace dialysis and native kidney transplantation. Additionally, the same technology is being used to develop a portable wearable artificial kidney, a portable tabletop device, and ultimately an implantable artificial kidney.

USKRC is currently finishing their portable prototypes. The company says that with adequate funding their backpack and tabletop portable prototypes can be completed and ready for clinical trials within 2 to 2 1/2- years.

The company’s future plans include advancing their technology, miniaturizing their prototype for use in an implantable artificial kidney. The company is also advancing their new non-clotting filtering technology, PD dialysate regeneration, and studying the role of middle molecules (uremic toxins) including a method to detect, identify, and isolate them.

USKRC is working with Dr. Ira Kurtz, their Science/Medical Advisor/Board Member, whom also is the Chief of Nephrology at the University of California Los Angeles (UCLA) and with researchers from the Department of Chemical Engineering at the University of Arkansas, headed by Dr. Jamie Hestekin.

Website: uskidneyresearchcorp.com